[The metabolic syndrome as intrahepatocytic Cushing's syndrome]

Endocrinol Nutr. 2011 Apr;58(4):153-6. doi: 10.1016/j.endonu.2010.12.003. Epub 2011 Mar 2.
[Article in Spanish]
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 / antagonists & inhibitors
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 / metabolism
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2 / metabolism
  • Adipose Tissue / enzymology
  • Animals
  • Cortisone / metabolism
  • Diabetes Mellitus, Type 2 / enzymology
  • Gene Expression Regulation
  • Gluconeogenesis / drug effects
  • Gluconeogenesis / genetics
  • Hepatocytes / enzymology
  • Hepatocytes / metabolism*
  • Humans
  • Hydrocortisone / antagonists & inhibitors
  • Hydrocortisone / biosynthesis
  • Hydrocortisone / metabolism*
  • Insulin Resistance
  • Metabolic Syndrome / enzymology
  • Metabolic Syndrome / genetics
  • Metabolic Syndrome / physiopathology*
  • Obesity / etiology
  • Obesity / physiopathology
  • Receptors, Glucocorticoid / drug effects
  • Receptors, Glucocorticoid / metabolism
  • Thinness / metabolism

Substances

  • Receptors, Glucocorticoid
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
  • 11-beta-Hydroxysteroid Dehydrogenase Type 2
  • Cortisone
  • Hydrocortisone